(10)Fmoc-Gly-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin (10) Preparation of Fmoc-Gly-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin (9)Fmoc-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin(20DMF)5203DMF3DMF2Fmoc-Gly-OH0.7gDIEA0.4mlTBTU0.56gHOBT0.2gDMF10ml1.53DMF3DMF2Fmoc-Gly-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin In the Fmoc-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin in step (9), add a decapping reagent (20% piperidine in DMF) , reacted at room temperature for 5 minutes, drained, added decapping agent and reacted at room temperature for 20 minutes, washed 3 times with isopropanol, washed 3 times with DMF, washed 2 times with distilled DMF, drained, added Fmoc-Gly-OH0
BMC Dev Biol 13(1):34 Lam S (2011) Azilsartan: a newly approved angiotensin II receptor blocker
After it neutralizes a free radical, it becomes oxidized (GSSG)
For many companies, the technology is ready
Es gibt auerdem eine Osmolalitts-Diskrepanzion, was bedeutet, dass die Konzentration der gelsten Partikel in der Injektion nicht mit deiner Zwischenflssigkeit bereinstimmt
